IPC Login     |     Portal Login     |     search arrow  
     

Office of Technology Transfer

 
 

About OTT

Media

  News
  Events
  Annual Reports
  Presentations

Inventor Resources

Available Technologies

Plant Varieties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Archived News

2007:


7.10.2007

LaamScience Nears First Product Rollout

LaamScience Inc., Research Triangle Park, N.C., a start-up company that is developing commercial products based on light-activated antimicrobial nanotechnology, reports it has raised more than $2 million to fund continued research, business operations and marketing as it nears its first product rollout.

 

7.06.2007

NC State Names Director of Office of Technology Transfer

NC State named Mr. Billy Houghteling Director of the Office of Technology Transfer (OTT) effective July 1, 2007.

 

6.19.2007

NC State Commercialization Partner, Diversified Energy Corporation, Announces Biogasoline Technology

NC State University has filed a provisional patent describing a cost-effective, "green" method to produce biogasoline, in partnership with Diversified Energy Corporation (DEC), an Arizona-based company specializing in the development of advanced alternative and renewable energy technologies.

4.02.2007

EPA Grants Official Registration for Child-Safe Insect Repellent
NC State Research Poised to Make Your Summer Even Better

The U.S. Environmental Protection Agency (EPA) has officially approved BioUD™ as a safe active ingredient in insect repellent for direct skin application with no child restrictions. HOMS, LLC, a North Carolina-based biotech company, will immediately begin distribution of the BioUD ™ formula in a product called Bite Blocker.

 

2006:


11.28.2006

Biolex Announces Potential to Produce Monoclonal Antibodies with Increased Potency & Efficacy

Monoclonal antibodies comprise one of the fastest growing classes of protein therapeutics and are currently being used and developed primarily to treat cancers, autoimmune diseases, infectious diseases and inflammatory diseases.  Biolex Therapeutics, an NC State start-up company, announced results publishes in Nature Biotechnology demonstrating the ability of its proprietary LEX System to produce monoclonal antibodies that have enhanced in vitro potency and efficacy.

 

11.15.2006

Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology

Pfizer Animal Health, a division of Pfizer Inc (NYSE: PFE) has agreed to acquire Embrex, Inc. (NASDAQ: EMBX), an international agricultural biotechnology company known for its Inovoject® vaccine-delivery systems, the companies announced today.  Founded in 1985, Embrex began as an NC State start up and is now an international agricultural biotechnology company focused on developing and providing in ovo solutions that meet the needs of the global poultry industry.

 

06.27.2006

Nitronex Corporation, an NC State Spin-Out and Leading Developer of GaN-on-Silicon Technology Works with sp3 on Phase II SBIR Award

sp3 Diamond Technologies, Inc., a supplier of wafer scale diamond and diamond products for solving thermal management challenges in high-performance applications, announces receipt of a $750,000 Phase II contract from the Missile Defense Agency (MDA) for GaN on silicon-on-diamond (SOD) development.

 

4.28.2006

NC State Researcher Creates New Material: Magnetic Liquid

Micrograph of a metal-rich, zincchloride-based liquid crystal. Dr. James Martin of NC State's Department of Chemistry is the first researcher to engineer liquid crystals with exceptionally high concentrations of metallic compounds. This discovery has the potential to revolutionize electronic, optic and magnetic products.

 

4.27.2006

NC State Start-Up, Biolex Therapauetics, Reports Positive Results of its Hepatitis C Product Candidate

Biolex Therapeutics announces positive Phase I results for Hepatitis C product candidate -- Locteron. The NC State start-up company is advancing a proprietary pipeline of product candidates for the treatment of hepatitis C under joint development with OctoPlus.

4.2006

Trana Discovery Teams with Former Glaxo Executives to Fight Drug- Resistant Infectious Diseases

Executives with big-company resumes not only bring scores of industry contacts, they can raise a startup's chances of attracting investments.  Trana Discovery founders want to use the executives' experience and connections to expand the business and attract outside investing.

3.2006

Garden Design Magazine selects NC State sweet potato ornamental as a premiere plant of 2006

"Sweet Caroline Red" named 8th in the WAY HOT 100!

 

 

 

The mission of the Office of Technology Transfer is to move academic discovery to the marketplace resulting in new products, processes, and companies while maximizing the impact of academic research and forging new partnerships to tackle 21st century issues.

 

OTT Home        NC State Home        Contact Us        FAQs        Customer Service Feedback        Talk to the Director

Copyright NCSU, 2007